AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Insulet to Present at Upcoming Investor Conferences

February 19, 2019

ACTON, Mass.--(BUSINESS WIRE)--Feb 19, 2019--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences:

To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com. Replays of the webcasts will also be available following the events.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. Founded in 2000, Insulet has more than 150,000 users across the globe who rely on its Omnipod Insulin Management System to bring simplicity and freedom to their lives.

For more information, please visit: www.insulet.com and www.myomnipod.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190219005877/en/

CONTACT: Investor Relations and Media Contact:

Deborah R. Gordon

Vice President, Investor Relations and Corporate Communications

(978) 600-7717

dgordon@insulet.com

KEYWORD: UNITED STATES NORTH AMERICA FLORIDA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES OTHER HEALTH DIABETES

SOURCE: Insulet Corporation

Copyright Business Wire 2019.

PUB: 02/19/2019 04:01 PM/DISC: 02/19/2019 04:01 PM

http://www.businesswire.com/news/home/20190219005877/en